Novartis Field Medical Reorg 2012

Discussion in 'MSL Board' started by Anonymous, Dec 31, 2011 at 6:48 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    What have you heard?
     

  2. Anonymous

    Anonymous Guest

    FWIW - I've seen increase activity among my Novartis LinkedIn contacts.
     
  3. Anonymous

    Anonymous Guest

    Here they go again...

    1) Lost Tekturna and its product family - huge loss in cardiovascular space

    2) Gilenya - is it doing as well is it should be?

    3) Vaccines - only need so many people covering these products

    4) Oncology - ??

    At least KM is no longer around.
     
  4. Anonymous

    Anonymous Guest

    Usman Azam is better?
     
  5. Anonymous

    Anonymous Guest

    How did the reorg go